Serum Institute of India

Covid-19: 10 Crore Doses of SII's Covovax Approved for Exports by Govt Lab, Stock Rolled Out for Teens

Serum Institute of India, World's Largest Vaccine Maker, Halts Production of Covishield

SII CEO Adar Poonawalla: Covishield Booster At Rs 600 Plus Tax, Covovax on Cowin in 10-14 Days

Amit Shah Unveils Book Chronicling Journey of SII's Covishield from Lab to People

Serum Institute Seeks Covovax's Inclusion in Covid Vaccination Drive for 12 Years & Above

DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group

SII Makes Available Vaccines at Price of 'Cup of Tea' to Poor Nations, Says Poonawalla

Serum Institute Sells Jabs at Price of a 'Cup of Tea' to Poor Nations, Says Cyrus Poonawalla

6 Crore Corbevax, 3 Crore Covovax Doses Cleared by Govt Lab; Panel Nod Awaited for Use Among Kids in India

Govt Expert Panel Seeks More Data from SII, Bharat Biotech for Full Market Approval for Covaxin, Covishield

Over 100 Cr Covishield Doses Given in India, Abroad Testimony of Its Safety, Efficacy: SII

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII